KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers.

doi:10.1038/bjc.2013.118

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers.

British journal of cancer - 30 Apr 2013

Phipps A I, Buchanan D D, Makar K W, Win A K, Baron J A, Lindor N M, Potter J D, Newcomb P A

Abstract excerpt

BACKGROUND: Mutations in the Kirsten Ras (KRAS) oncogene are common in colorectal cancer (CRC). The role of KRAS-mutation status as a prognostic factor, however, is unclear. We evaluated the relationship between KRAS-mutation status and CRC survival, considering heterogeneity in this association...

Topics

Adult
Aged
Colorectal Neoplasms
Female
Genes, ras
Humans
Male
Middle Aged
Mutation
SEER Program
Survival Rate
Washington
Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 23511557
DOI: 10.1038/bjc.2013.118
PMCID: PMC3668469

Genes

KRAS
BRAF

Variants

Provenance

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-23511557-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.